12:00 AM
 | 
Mar 04, 2013
 |  BC Week In Review  |  Company News  |  Sales & Marketing

Cipla, Lallemand Inc. sales and marketing update

Lallemand's Lallemand Pharma AG affiliate granted Cipla rights to commercialize Polyvalent Mechanical Bacterial Lysates-based immunostimulant under the...

Read the full 63 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >